JPH01254628A - Agent for depressing consciousness level - Google Patents
Agent for depressing consciousness levelInfo
- Publication number
- JPH01254628A JPH01254628A JP63083715A JP8371588A JPH01254628A JP H01254628 A JPH01254628 A JP H01254628A JP 63083715 A JP63083715 A JP 63083715A JP 8371588 A JP8371588 A JP 8371588A JP H01254628 A JPH01254628 A JP H01254628A
- Authority
- JP
- Japan
- Prior art keywords
- fraction
- valerian
- effect
- fragrance
- vacuum distillation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000881 depressing effect Effects 0.000 title description 3
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 30
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 30
- 235000016788 valerian Nutrition 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 238000005292 vacuum distillation Methods 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 abstract description 24
- 239000002304 perfume Substances 0.000 abstract description 13
- 208000019901 Anxiety disease Diseases 0.000 abstract description 4
- 230000036506 anxiety Effects 0.000 abstract description 4
- 235000019645 odor Nutrition 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 3
- 235000019565 spicy aroma Nutrition 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 230000001914 calming effect Effects 0.000 description 12
- 230000001624 sedative effect Effects 0.000 description 11
- 239000000341 volatile oil Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 239000000344 soap Substances 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000012437 perfumed product Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 238000000222 aromatherapy Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- 239000002386 air freshener Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000530 Alcea rosea Species 0.000 description 1
- 235000017334 Alcea rosea Nutrition 0.000 description 1
- 235000017303 Althaea rosea Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 102000012547 Olfactory receptors Human genes 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 241000792914 Valeriana Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- -1 ange Species 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 235000017468 valeriana Nutrition 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Detergent Compositions (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、ヒトまたは動物の意識水準を鎮静させる、減
圧蒸留により、気圧0.08mmHgの下で、80℃以
前に留出する部分を除いたバレリアン油分画部を吸入さ
せることにより、ヒトまたは動物の意識水準を鎮静させ
る組成物に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention provides a method for sedating the conscious level of humans or animals by vacuum distillation under an atmospheric pressure of 0.08 mmHg, except for the part distilled out at temperatures below 80°C. The present invention relates to a composition for sedating the conscious level of a human or animal by inhaling a valerian oil fraction.
[従来の技術]
従来から、香料などの芳香物質を吸入させることにより
心身のコントロールを行う、いわゆるアロマテラピー(
芳香療法)という治療方法が知られている。このアロマ
テラピーの中で用いられてきた香料は古米からの伝承を
もとにした天然精油が中心であり、本発明で問題として
いる「意識水準を静める効果」に関しては、ラベンダー
、ベルガモツト、マジョラム、ローズ、メース、ジンジ
ャ−、タイム、ナツメッグ、クラリセージ、シンナモン
等の精油が効果が高いとされている(奥田冶r 7’O
”?テラヒーFfl望J香’14 ;No、140 (
1983)pp、 19−26 )
またP、Rove s t iらの研究グループは、ワ
イルドミント、マジョラム、ラベンダー、ブチグレン、
ローズ、カンファー、ネロリ、ベルガモツト、セージ、
シブレス、ミルテ、バレリアンウォームウッド、カモミ
ル、ゼラニウム、ヤローホリーホック、オレンジブロツ
サム、ミント等の単品精油、あるいはアカシア、ファー
ジ、ガーデニア、ネロリ、オボボナックス、ローズ、ラ
イラック等を基本とした混合物をエアゾールを用いて心
理的不安症収や心理的緊張症賦に悩む神経症思考に吸入
投与したところ鎮静剤をあたえた時のような効果が得ら
れたとしている。(S、P、CAug47しかしながら
、これらの効果は、主観的かつ定性的なもので、有効性
の点で必ずしも満足し得ないものである。また上記の精
油は、強い香りを持つものが多く、調香により調合香料
を作成する場合に全体の香りにi7J 12Fを与えて
しまうことから、香りの強度及び嗜好性と効果発現の有
効量とのバランスについても必ずしも満足しえないもの
であった。上記のI’Lovestiの効果精油の中で
、バレリアン精油は、古来からヒステリーの鎮静薬とし
て知られ、薬学事典の一部にも、香りによる鎮静効果の
記載があり、最も有名な鎮静効果を持つ精油とされてき
たが、二オイ主成分が悪臭を持つ吉草酸とその誘導体で
あり、香料成分として用いる場合、特に嗜好性の点で劣
っているものであった。[Prior Art] Traditionally, so-called aromatherapy (
A treatment method called aroma therapy is known. The fragrances that have been used in aromatherapy are mainly natural essential oils that have been handed down from ancient America, and in terms of the ``effect of calming the level of consciousness'' that is the issue of the present invention, lavender, bergamot, marjoram, Essential oils such as rose, mace, ginger, thyme, nutmeg, clary sage, and cinnamon are said to be highly effective (Osamu Okuda 7'O
"? Terrahy Ffl Nozomi Jaka'14; No, 140 (
1983) pp, 19-26) In addition, the research group of P. Rovesti et al.
Rose, camphor, neroli, bergamot, sage,
Using aerosols, you can use single essential oils such as civet, myrte, valerian wormwood, chamomile, geranium, yarrow hollyhock, orange blossom, mint, etc., or mixtures based on acacia, phage, gardenia, neroli, ovobonax, rose, lilac, etc. When administered by inhalation to neurotic thinking patients suffering from psychological anxiety or psychological tension, it was reported that the effect was similar to that of a sedative. (S, P, CAug47 However, these effects are subjective and qualitative, and their effectiveness is not necessarily satisfactory.In addition, many of the essential oils mentioned above have strong scents, Since i7J 12F is imparted to the overall fragrance when creating a blended fragrance by perfume mixing, the balance between the intensity and palatability of the fragrance and the effective amount for producing effects cannot always be satisfied. Among the effective essential oils of I'Lovesti mentioned above, valerian essential oil has been known as a sedative for hysteria since ancient times, and some pharmaceutical encyclopedias also mention its sedative effect due to its scent, and it has the most famous sedative effect. Although it has been considered as an essential oil, the main components are valeric acid and its derivatives, which have a bad odor, and when used as a fragrance ingredient, it has poor palatability.
[発明が解決しようとする課題]
本発明者は上記事情に鑑み、悪臭が無く、真に意識水準
を鎮静させる効果に優れたバレリアン精油を得るべく鋭
意研究を重ねた結果、0.08mmHgの減圧下で行う
蒸留により、80℃以前に流出する部分を除いたバレリ
アン分画部が、ウツデイ・スパイシイな芳香を有し、悪
臭成分が無いにもかかわらず、吸入により強力な意識水
準を鎮静させる効果を有するという全く新規な事実を見
出し、この知見にもとづいて本発明を完成するに至った
。[Problems to be Solved by the Invention] In view of the above circumstances, the present inventor conducted intensive research to obtain valerian essential oil, which has no bad odor and has an excellent effect of truly calming the level of consciousness. Through distillation below, the valerian fraction, excluding the part that flows out below 80℃, has a depressing, spicy aroma, and although it has no malodorous components, it has a strong sedative effect on the level of consciousness when inhaled. We have discovered the completely new fact that the present invention has the following properties, and based on this knowledge, we have completed the present invention.
[課題を解決するための手段]
すなわち本発明は、減圧蒸留により、気圧0゜08 m
m Hgの下で蒸留分画し、80℃以前に留出する部
分を除いたバレリアン油分画部(以下、°°バレリアン
活性分画部”と略す。)を有効成分として配合したこと
を特徴とするヒトまたは動物の意識水準を鎮静させる組
成物である。[Means for Solving the Problems] That is, the present invention uses vacuum distillation to reduce the atmospheric pressure to 0°08 m.
It is characterized by containing as an active ingredient a valerian oil fraction (hereinafter abbreviated as "valerian active fraction") obtained by distillation fractionation under mHg and excluding the part distilled out at temperatures below 80°C. A composition that sedates the level of consciousness of a human or animal.
ここで言う意識水準を鎮静させる効果とは、ヒトまたは
動物が日常生活で経験するイライラ、不安感、緊張など
の意識水準の過度の高揚による生理心理的状態から開放
し、気分を穏やかにするとともに精神活動を平常化させ
る効果をさすものである。The effect of calming the level of consciousness referred to here refers to the effect of relieving humans or animals from the physiological and psychological states caused by excessively elevated levels of consciousness such as irritation, anxiety, and tension that they experience in their daily lives, and calming their mood. It refers to the effect of normalizing mental activity.
また、組成物とは、”バレリアン活性分画部”が有効量
吸入され、嗅覚受容体を刺激もしくは経気道的に体内に
吸収されることにより効果が発現するものを指し、香水
、コロン、室内芳香剤、などのフレグランス製品の他、
石鹸、歯磨などの化粧石、医薬品なども包括するもので
ある。In addition, the term "composition" refers to a composition in which an effective amount of "active fraction of valerian" is inhaled to stimulate olfactory receptors or to be absorbed into the body through the respiratory tract, producing an effect. In addition to fragrance products such as air fresheners,
It also includes cosmetic stones such as soap and toothpaste, and pharmaceuticals.
以下本発明について詳しく説明する。The present invention will be explained in detail below.
本発明における”バレリアン活性分画部”は、公知の物
質であり、バレリアン油を気圧0.08m m l−1
gの下で蒸留分画し、80℃以前に留出する部分を除い
たバレリアン油分画部で、バレリアン精油の高沸点成分
の混合物である。The "valerian active fraction" in the present invention is a known substance, and valerian oil is heated at an atmospheric pressure of 0.08 mm l-1.
This is a valerian oil fraction that is distilled under 80° C. and is a mixture of high-boiling components of valerian essential oil.
バレリアン油分画部については、標準商業品種の、Va
lerlan root oil(山本香料)の分
画部が本発明に用いられるが、日本産中国産、欧州産等
全てのバレリアン油のどのような成分組成を持つものの
分画部でも用いることが出来る。For the valerian oil fraction, the standard commercial variety, Va.
The fractionated part of lerlan root oil (Yamamoto Co., Ltd.) is used in the present invention, but any fractionated part of any component composition of valerian oil from Japan, China, Europe, etc. can also be used.
さらに天然のバレリアンから蒸留、抽出等の方法で得ら
れた精油の分画部を本発明に用いることが出来る。Furthermore, a fraction of essential oil obtained from natural valerian by methods such as distillation and extraction can be used in the present invention.
従って、バレリアン(Valeriana 。Therefore, Valeriana.
ff1clnalls L、及びその亜種)の根茎か
ら水蒸気蒸留、抽出など種々の手段により得られた香l
ト混合物を減圧蒸留することによって、効果分画部を得
ることも出来る。ff1clnalls L and its subspecies) obtained by various means such as steam distillation and extraction.
An effective fraction can also be obtained by distilling the mixture under reduced pressure.
”バレリアン活性分画部°°は減圧蒸留以外にも常圧蒸
留、カラムクロマトグラフィー、GC分取等の方法で得
ることが出来るが、工業的な観点からは減圧蒸留が望ま
しいと考えられる。``The valerian active fraction can be obtained by other methods than vacuum distillation, such as atmospheric distillation, column chromatography, and GC fractionation, but from an industrial standpoint, vacuum distillation is considered preferable.
これらの“バレリアン活性分画部”は、単独または”バ
レリアン活性分画部”と混合可能な様々な媒体(例えば
エタノール、調香料、賦香製品)との混合組成物として
用いられる。These "valerian active fractions" can be used alone or in mixed compositions with various media that can be mixed with the "valerian active fraction" (eg, ethanol, perfumes, perfumed products).
媒体に調合香料を用いる場合は、調合香料全体の香りは
個々の成分の香りが寄与することとなるが、前述の通り
”バレリアン活性分画部”は悪臭が無く、弱いウツデイ
・スパイシイな芳香を有するから調合香料全体の芳香の
バランスに悪影響を与えない。When a blended fragrance is used as a medium, the scent of each individual component contributes to the overall scent of the blended fragrance, but as mentioned above, the "active fraction of valerian" does not have a bad odor and has a weak, depressing, spicy aroma. It does not have a negative effect on the aroma balance of the entire blended fragrance.
この点から”バレリアン活性分画部°′の使用量はかな
り自由度が高く”バレリアン活性分画部゛を重量比で1
%以上調合香料に配合しても全体の香調のバランスをそ
こなうことなく意識鎮静効果を発現させることができる
。From this point of view, there is a high degree of freedom in the amount of ``valerian active fraction'' used.
Even if it is added to a blended fragrance in an amount of % or more, it is possible to produce a conscious sedative effect without impairing the balance of the overall fragrance tone.
さらに意識鎮静効果を顕著に発現させるという観点から
見た場合”バレリアン活性分画部゛を重量比で5%から
50%の範囲で調合香料中に配合することが出来る。Furthermore, from the viewpoint of significantly producing a conscious sedative effect, it is possible to incorporate ``valerian active fraction'' in a range of 5% to 50% by weight in a blended fragrance.
また、媒体として゛バレリアン活性分画部”単独または
上に記載した”パレリアン活性分画部“を含有する芒料
組成物をエチルアルコールと混合し、オーデコロンとし
て用いることも出来る。Further, a balm composition containing the "valerian active fraction" alone or the above-mentioned "palerian active fraction" as a medium can be mixed with ethyl alcohol and used as an eau de cologne.
また”バレリアン活性分画部°°単独、または上に記載
した゛バレリアン活性分画部゛°を含有する香料組成物
を用いて、担体としての賦香製品に賦香することもでき
る。そのような賦香製品とじては、フレグランス、室内
芳香剤、クリーム、乳液化粧パウダー、ボディローショ
ン、デオドラントスティック、歯磨、頭髪製品、エアゾ
ール製品などがある。It is also possible to use the active fraction of valerian alone or the fragrance compositions containing the active fraction of valerian described above to perfume a perfumed product as a carrier. Perfumed products include fragrances, room air fresheners, creams, emulsion cosmetic powders, body lotions, deodorant sticks, toothpastes, hair products, and aerosol products.
さらに”バレリアン活性分画部゛°を有効成分とする吸
入医薬品としても用いることが出来る。Furthermore, it can also be used as an inhalation drug containing the active fraction of valerian as an active ingredient.
[薬理効果]
1、マウスに対する麻酔薬作用時間延長効果(1)実験
方法
ICR系雄性マウス(6〜7週齢、体重80〜35g)
に、下記の被験物質を含む空気流(1〜2mgの被験物
質を含む空気を毎分21供給)f!0:4時間吸入させ
た群と、物質を吸入させない群のベンドパルビタール睡
眠時間(55mg/kg腹注)の差を比較した。[Pharmacological effects] 1. Effect of prolonging the anesthetic action time on mice (1) Experimental method ICR male mice (6-7 weeks old, weight 80-35 g)
, an air flow containing the test substance (21 air per minute containing 1-2 mg of test substance) f! The difference in bendoparbital sleep time (55 mg/kg intraperitoneal injection) was compared between a group in which the substance was inhaled for 0:4 hours and a group in which the substance was not inhaled.
(2)被験物質
物質A:Valerlan root oil(山
本香料より人手)
物質B:”バレリアン活性分画部°。(2) Test substance Substance A: Valerlan root oil (manufactured by Yamamoto Co., Ltd.) Substance B: “Valerian active fraction °.
実験結果を表、1に示す。The experimental results are shown in Table 1.
表、1
吸入群の平均睡眠時間が延長したことを示、負のものは
短縮したことを示す。Table 1 shows that the average sleeping time of the inhalation group was prolonged; negative values indicate that it was shortened.
[投与方法、投与量]
本発明は吸入による投与を特徴とするものであり経口投
与、皮下注射、筋肉注射などによる興奮剤とはとは異な
り、健常人に対して与えた場合に興奮剤よりも緩和な意
識鎮静効果を期待するもの゛ であるから上に述べた
”バレリアン活性分画部°゛をアルコールあるいは香料
などを含む組成物の一部として、または賦香製品に用い
られた香料の組成物の一部として与えることが望ましい
。[Administration Method and Dose] The present invention is characterized by administration by inhalation, and unlike stimulants administered orally, subcutaneously, or intramuscularly, it is more effective than stimulants when given to healthy individuals. Since valerian is expected to have a mild sedative effect, the above-mentioned ``valerian active fraction'' may be used as part of a composition containing alcohol or fragrance, or as part of a fragrance used in perfumed products. Preferably, it is given as part of a composition.
本発明の意識を鎮静させる吸入剤の効果は年齢個人差、
性別、心身状態などに影2′!されるので、場合によっ
ては下記範囲外量を投与する場合も生ずるが、一般に健
常人を対象とする場合”パレリアシ活性分画部”を0.
1%から5%含む賦香製品から揮散する香気により”バ
レリアン活性分画部”を有効量一定時間あるいは継続的
に吸入投与することが好ましい。The effectiveness of the sedative inhaler of the present invention varies by age,
Shadow 2' in gender, mental and physical condition, etc.! Therefore, in some cases, doses outside the range shown below may be administered, but in general, when administering to healthy individuals, the dose of "parelliasis active fraction" is 0.
It is preferable to administer an effective amount of "valerian active fraction" by inhalation over a certain period of time or continuously by means of the aroma volatilized from a flavored product containing 1% to 5%.
[実施例]
つぎに実施例および比較例をあげて、本発明を具体的に
明らかにする。本発明はこれにより限定されるものでは
ない。配合量は重量%である。[Examples] Next, examples and comparative examples will be given to specifically clarify the present invention. The present invention is not limited thereby. The blending amount is in weight%.
実施例1 香水及びオーデコロン
標準商業品種の”活性物質”を重量濃度で、それぞれ5
%、10%15%、20%加えた柑橘系の香りをもつフ
レグランス用調合香料を95%の水性アルコールに重量
濃度で3%になるように溶解し、オーデコロンを調製す
る。また同じ調合香料を95%水性アルコールに重量濃
度で20%になるように溶解して香水とする。Example 1 "Active substances" of standard commercial varieties of perfumes and colognes, each at a weight concentration of 5
%, 10%, 15%, and 20% of a fragrance preparation with a citrus scent is dissolved in 95% aqueous alcohol to a weight concentration of 3% to prepare an eau de cologne. Further, the same blended fragrance is dissolved in 95% aqueous alcohol to a weight concentration of 20% to prepare a perfume.
これらのオーデコロンは香気吸入により人間の意識水準
を鎮静させる効果を持つ。These colognes have the effect of calming the human consciousness level by inhaling their scent.
実施例2 室内用エアスプレー 以下の処方によりエアゾールに充填した。Example 2 Indoor air spray The aerosol was filled according to the following formulation.
”バレリアン活性分画部” f!:15%含む調香料(
以下、効果調香1’4 Aと略す。) 5工チルア
ルコール95% 56スバン 85
2ツイン 81
1これらのエアゾールは香気吸入により、
人間の意識水準を鎮静させる効果を持つ。“Valerian active fraction” f! : Contains 15% fragrance (
Hereinafter, it will be abbreviated as effect perfume 1'4A. ) 5-functional alcohol 95% 56 Suban 85
2 twin 81
1 These aerosols can be used by inhaling the aroma.
It has the effect of calming the level of human consciousness.
実施例8 石鹸
(1)石鹸素地 95.0(
2)効果調査料A5.0
(3)色素 3f!J量製
法
(2)及び(3)を石けん素地に添加後2機械練り、あ
るいは枠線りして石けんを製造した。Example 8 Soap (1) Soap base 95.0 (
2) Effect research fee A5.0 (3) Pigment 3f! Soaps were manufactured by adding the J amount manufacturing methods (2) and (3) to the soap base and then kneading it in two machines or forming a border.
これらの石鹸は使用時の香気吸入により人間の意識水準
を鎮静させる効果を持つ。These soaps have the effect of calming the human consciousness level by inhaling the aroma when used.
実施例4 シャンプー
(1)アルキル硫酸トリエタノールアミン塩 15.0
(2)ヤシ脂肪酸モノエタノールアミド 5.0(
3)エチレングリコールモノステアレート2.0(4)
防腐剤 適量(5)色素
適量(6)効果調香
4t4A 3.0(7)精製
水 残余製法
(1)〜(6)を(7)中に撹拌溶解しシャンプーを得
た。Example 4 Shampoo (1) Alkyl sulfate triethanolamine salt 15.0
(2) Coconut fatty acid monoethanolamide 5.0 (
3) Ethylene glycol monostearate 2.0 (4)
Preservative: Appropriate amount (5) Pigment: Appropriate amount (6) Effect Perfume 4t4A 3.0 (7) Purified water Residual manufacturing methods (1) to (6) were dissolved in (7) with stirring to obtain a shampoo.
これらのシャンプーは使用時の香気吸入により人間の意
識水準を鎮静させる効果を持つ。These shampoos have the effect of calming the human consciousness level by inhaling the fragrance when used.
実施例5 ヘアリンス
(1)塩化アルキル
トリメチルアンモニウム 3.0(2)セチルア
ルコール 1.0(3)防腐剤
0.1(4)グリセリン
5.0(5)効果調香料A
0.4(6)色素
適量(7)POE(8モル)ステ
アリルエーテル 0.6(8)精製水
残余製法
(1)〜(8)を80℃にて混合溶解し、室温まで放冷
してヘアリンスを得た。Example 5 Hair rinse (1) Alkyltrimethylammonium chloride 3.0 (2) Cetyl alcohol 1.0 (3) Preservative
0.1(4) Glycerin
5.0 (5) Effect fragrance A
0.4(6) Pigment
Appropriate amount (7) POE (8 mol) Stearyl ether 0.6 (8) Purified water
The remaining production methods (1) to (8) were mixed and dissolved at 80°C, and the mixture was allowed to cool to room temperature to obtain a hair rinse.
これらのヘアリンスは使用時の香気吸入により人間の意
識水準を鎮静させる効果を持つ。These hair rinses have the effect of calming the human consciousness level by inhaling the scent when used.
実施例6 バスパウダー
(1)タルク 80,0
(2)効果香料組成物 20.0(
効果調香1”4 A 、流動パラフィン、1:20)製
法
(1)、 (2)を混合撹拌してバスパウダーを得た。Example 6 Bath powder (1) Talc 80.0
(2) Effective fragrance composition 20.0 (
Effect Perfume 1"4 A, liquid paraffin, 1:20) Manufacturing methods (1) and (2) were mixed and stirred to obtain a bath powder.
これらのバスパウダーは、使用時の香気吸入により人間
の意識水1を鎮静させる効果を持つ。These bath powders have the effect of calming the human conscious water 1 by inhaling the aroma when used.
実施例7 線香水
(1)効果香料組成物 90.0(
効果調査料A、ワセリン、5:4)
(2)トリミリスチン酸グリセリン 8.0(3
)香料 2.0製法
(1)〜(3)を混合撹拌して線香水を得た。Example 7 String perfume (1) Effective fragrance composition 90.0 (
Effect research fee A, Vaseline, 5:4) (2) Glyceryl trimyristate 8.0 (3)
) Perfume 2.0 Production Methods (1) to (3) were mixed and stirred to obtain a line perfume.
Cれらの線香水は、使用時の香気吸入により人間の意識
水準を鎮静させる効果を持つ。C. These line perfumes have the effect of calming the human consciousness level by inhaling the scent when used.
[発明の効果]
本発明は、ヒトまたは動物が日常生活で経験するイライ
ラ、不安感、緊張などの意識水準の過度の高揚による生
理心理的状態から開放し、気分を穏やかにするとともに
精神活動を平常化させるなどの意識水準を鎮静させる効
果を有するものである。[Effects of the Invention] The present invention relieves humans and animals from physiological and psychological states caused by excessively elevated levels of consciousness such as irritation, anxiety, and tension that they experience in their daily lives, calms their mood, and reduces mental activity. It has the effect of calming the level of consciousness by bringing it back to normal.
特許出願人 株式会社 資 生 堂Patent applicant: Shiseido Co., Ltd.
Claims (1)
前に留出する部分を除いたバレリアン油分画部を有効成
分として配合したことを特長とする、ヒトまたは動物の
意識水準を鎮静させる組成物。A composition that calms the level of consciousness of humans or animals, characterized in that it contains as an active ingredient a valerian oil fraction obtained by removing the part that distills out below 80°C under an atmospheric pressure of 0.08 mmHg by vacuum distillation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63083715A JP2652552B2 (en) | 1988-04-05 | 1988-04-05 | Composition for inhalation administration to calm the consciousness level |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63083715A JP2652552B2 (en) | 1988-04-05 | 1988-04-05 | Composition for inhalation administration to calm the consciousness level |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01254628A true JPH01254628A (en) | 1989-10-11 |
JP2652552B2 JP2652552B2 (en) | 1997-09-10 |
Family
ID=13810202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63083715A Expired - Lifetime JP2652552B2 (en) | 1988-04-05 | 1988-04-05 | Composition for inhalation administration to calm the consciousness level |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2652552B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04149136A (en) * | 1990-10-09 | 1992-05-22 | Kureha Chem Ind Co Ltd | Perfume composition and perfume product therefrom |
JPH0923851A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
JPH0923850A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
US6315980B1 (en) | 1998-09-25 | 2001-11-13 | Shiseido Company, Ltd. | Skin barrier function recovery and promotion composition and evaluation method thereof |
WO2001098442A1 (en) * | 2000-06-20 | 2001-12-27 | Shiseido Co., Ltd. | Stress-relieving perfumes and stress-relieving perfume compositions containing the same |
WO2002053151A1 (en) * | 2001-08-08 | 2002-07-11 | Shiseido Company, Ltd. | Perfume compositions |
WO2002030377A3 (en) * | 2000-10-09 | 2002-07-18 | Karen Croissant | Product for cleaning teeth and/or the mouth |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10918684B2 (en) * | 2009-08-17 | 2021-02-16 | Cqens Technologies, Inc. | Vaporized medicants and methods of use |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5670096A (en) * | 1979-11-12 | 1981-06-11 | Takasago Perfumery Co Ltd | Manufacture of lemon oil having no phototoxicity |
JPS58127797A (en) * | 1982-01-25 | 1983-07-29 | 小林香料株式会社 | Purification of bergamot oil |
JPS598391A (en) * | 1982-07-05 | 1984-01-17 | 日本電気株式会社 | Solder plate for mounting planarly |
JPS5968399A (en) * | 1982-10-13 | 1984-04-18 | 株式会社 小林コ−セ− | Manufacture of low sensitive low irritant jasmine oil |
JPS606993A (en) * | 1983-05-11 | 1985-01-14 | インタ−ナショナル ビジネス マシ−ンズ コ−ポレ−ション | Word processing system |
JPS606992A (en) * | 1983-06-27 | 1985-01-14 | 株式会社日立製作所 | Display unit |
JPS6017479A (en) * | 1983-07-09 | 1985-01-29 | キヤノン株式会社 | Electric circuit substrate |
JPS6019955A (en) * | 1983-07-01 | 1985-02-01 | ロ−ベルト・ボツシユ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Fuel injection pump for internal combustion engine |
JPS6191297A (en) * | 1984-10-12 | 1986-05-09 | カネボウ株式会社 | Production of iran oil excellent in flavor and low in sensitivity |
JPS6284194A (en) * | 1985-10-08 | 1987-04-17 | カネボウ株式会社 | Production of iranian oil excellent in flavor and low in sensitivity |
JPS62275199A (en) * | 1986-05-22 | 1987-11-30 | 長谷川香料株式会社 | Non-phototoxic orange flower essential oil |
-
1988
- 1988-04-05 JP JP63083715A patent/JP2652552B2/en not_active Expired - Lifetime
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5670096A (en) * | 1979-11-12 | 1981-06-11 | Takasago Perfumery Co Ltd | Manufacture of lemon oil having no phototoxicity |
JPS58127797A (en) * | 1982-01-25 | 1983-07-29 | 小林香料株式会社 | Purification of bergamot oil |
JPS598391A (en) * | 1982-07-05 | 1984-01-17 | 日本電気株式会社 | Solder plate for mounting planarly |
JPS5968399A (en) * | 1982-10-13 | 1984-04-18 | 株式会社 小林コ−セ− | Manufacture of low sensitive low irritant jasmine oil |
JPS606993A (en) * | 1983-05-11 | 1985-01-14 | インタ−ナショナル ビジネス マシ−ンズ コ−ポレ−ション | Word processing system |
JPS606992A (en) * | 1983-06-27 | 1985-01-14 | 株式会社日立製作所 | Display unit |
JPS6019955A (en) * | 1983-07-01 | 1985-02-01 | ロ−ベルト・ボツシユ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Fuel injection pump for internal combustion engine |
JPS6017479A (en) * | 1983-07-09 | 1985-01-29 | キヤノン株式会社 | Electric circuit substrate |
JPS6191297A (en) * | 1984-10-12 | 1986-05-09 | カネボウ株式会社 | Production of iran oil excellent in flavor and low in sensitivity |
JPS6284194A (en) * | 1985-10-08 | 1987-04-17 | カネボウ株式会社 | Production of iranian oil excellent in flavor and low in sensitivity |
JPS62275199A (en) * | 1986-05-22 | 1987-11-30 | 長谷川香料株式会社 | Non-phototoxic orange flower essential oil |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04149136A (en) * | 1990-10-09 | 1992-05-22 | Kureha Chem Ind Co Ltd | Perfume composition and perfume product therefrom |
JPH0923851A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
JPH0923850A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
US6315980B1 (en) | 1998-09-25 | 2001-11-13 | Shiseido Company, Ltd. | Skin barrier function recovery and promotion composition and evaluation method thereof |
WO2001098442A1 (en) * | 2000-06-20 | 2001-12-27 | Shiseido Co., Ltd. | Stress-relieving perfumes and stress-relieving perfume compositions containing the same |
CN1307296C (en) * | 2000-06-20 | 2007-03-28 | 株式会社资生堂 | Stress-relieving perfumes and stress-relieving perfume compsns. contg. same |
WO2002030377A3 (en) * | 2000-10-09 | 2002-07-18 | Karen Croissant | Product for cleaning teeth and/or the mouth |
WO2002053151A1 (en) * | 2001-08-08 | 2002-07-11 | Shiseido Company, Ltd. | Perfume compositions |
Also Published As
Publication number | Publication date |
---|---|
JP2652552B2 (en) | 1997-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7169746B2 (en) | Perfume composition | |
JP2003119490A (en) | Psychosedative perfume composition | |
JP2002088391A (en) | Method for reinforcing smell and persistence of perfume and reinforcing agent | |
JP2001019992A (en) | Exhilarating agent and exhilarating perfume composition | |
JPH01254628A (en) | Agent for depressing consciousness level | |
JP2007197334A (en) | Composition for autonomic nerve regulator, sleep improving agent or stress relaxant | |
JP3590274B2 (en) | Sedative for vaporizing inhalation and sedative fragrance composition containing the same as an active ingredient | |
JPH01254629A (en) | Agent for raising consciousness level | |
JP5019016B2 (en) | Sleep improver and fragrance preparation | |
JP2676543B2 (en) | Awareness lowering agent | |
JP2009051770A (en) | Appetite suppressant composition | |
JP4547193B2 (en) | Fragrance composition | |
JP5306159B2 (en) | Method for imparting mental enhancement effect in fragrance composition | |
JPS63250315A (en) | Composition for promoting level of consciousness | |
JP3659665B2 (en) | Idea promoter | |
JP2003119491A (en) | Perfume composition for psychological exhilaranttion | |
JPH11343497A (en) | Cosmetic | |
JP2007031347A (en) | Composition for psychosedation | |
JP5478679B2 (en) | Fragrance composition and scented product for enhancing convenience | |
JP5127104B2 (en) | Fragrance composition and scented product for enhancing convenience | |
JP2801027B2 (en) | Immune function enhancer | |
JP4632895B2 (en) | Sleep improvement composition | |
JP2002234840A (en) | Uplifting agent and perfume composition having uplifting effect | |
JP5306160B2 (en) | Use of a specific fragrance component for producing a fragrance composition for mental sedation, and a method for imparting a mental sedative effect in the fragrance composition | |
JP2011105941A (en) | Method for reinforcing fragrance and persistence of perfume and reinforcing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |